Cellectis (CLLS) Cash from Operations (2015 - 2026)
Cellectis (CLLS) recorded quarterly Cash from Operations of 15410000.0 in Q1 2026, down 48.75% quarter-over-quarter from 10360000.0 in Q4 2025, and up 10.2% on a YoY basis from 13983902.7 in Q1 2025.
Cellectis (CLLS) Cash from Operations (2015 - 2026) Analysis & Trends
Cellectis' Cash from Operations history runs 12 years deep, the most recent figure standing at 15410000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 10.2% year-over-year to 15410000.0; the TTM figure through Mar 2026 stood at 37651000.0 (down 229.19% YoY), while the FY2025 annual figure was 39401000.0, down 271.39% from the prior year.
- Cash from Operations was 15410000.0 for Q1 2026 at Cellectis, down from 10360000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 52180000.0 in Q2 2024 to a low of 36612000.0 in Q1 2022.
- Historically, Cash from Operations has averaged 8257000.0 across 5 years, with a median of 15410000.0 in 2026.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations soared 3654.1% in 2023, then tumbled 21942.55% in 2025.
- A 5-year view of Cash from Operations shows it stood at 1220000.0 in 2022, then jumped by 3654.1% to 43360000.0 in 2023, then plunged by 100.11% to 47000.0 in 2024, then sank by 21942.55% to 10360000.0 in 2025, then sank by 48.75% to 15410000.0 in 2026.
- The last three Cash from Operations figures came in at 15410000.0 (Q1 2026), 10360000.0 (Q4 2025), and 1571000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | -15.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.41 Mn |
| Mar 31, 2026 | -15.41 Mn |
| Dec 31, 2025 | -10.36 Mn |
| Dec 31, 2025 | -10.36 Mn |
| Sep 30, 2025 | -1.57 Mn |
| Sep 30, 2025 | -1.57 Mn |
| Jun 30, 2025 | -10.31 Mn |
| Jun 30, 2025 | -10.31 Mn |
| Mar 31, 2025 | -17.16 Mn |
| Mar 31, 2025 | -17.16 Mn |
| Dec 31, 2024 | -47,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Sep 30, 2024 | -5.83 Mn |
| Sep 30, 2024 | -5.83 Mn |
| Jun 30, 2024 | 52.18 Mn |
| Jun 30, 2024 | 52.18 Mn |
| Mar 31, 2024 | -23.32 Mn |
| Mar 31, 2024 | -23.32 Mn |
| Dec 31, 2023 | 43.36 Mn |
| Dec 31, 2023 | 43.36 Mn |